Market Tracker

01/23 6:05pm ET

Cleveland Biolabs Inc (NASDAQ:CBLI)

0.25
Data as of Jan 23
 +0.019 / +8.23%
Today’s Change
0.19
Today|||52-Week Range
0.87
-12.28%
Year-to-Date
No recent news for Cleveland Biolabs Inc.

Today’s Trading

Previous close0.23
Today’s open0.26
Day’s range0.23 - 0.26
Volume260,659
Average volume (3 months)307,167
Market cap$14.3M
Dividend yield--
Data as of 4:00pm ET, 01/23/2015

Growth & Valuation

Earnings growth (last year)+22.45%
Earnings growth (this year)+63.94%
Earnings growth (next 5 years)--
Revenue growth (last year)+137.71%
P/E ratioNM
Price/Sales6.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KBIOKaloBios Pharmaceuti...+0.01+1.37%
CYCCCyclacel Pharmaceuti...-0.03-4.09%
ABIOARCA Biopharma Inc-0.01-1.41%
NYMXNymox Pharmaceutical...+0.02+4.25%
Data as of 4:00pm ET, 01/23/2015

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$8.5M
Annual profit (last year)-$17.3M
Net profit margin-203.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Yakov Kogan
Secretary, VP-Compliance &
Operations
Leah Brownlee
Corporate headquarters
Buffalo, New York

Forecasts